Free Trial

High Dividend Stocks List

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$9.55
+2.1%
$9.34
$8.08
$27.05
$8.26B0.6618.26 million shs29.75 million shs
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$57.33
+1.8%
$56.27
$39.35
$61.08
$116.28B0.4514.18 million shs45.94 million shs
Boston Properties, Inc. stock logo
BXP
Boston Properties
$74.64
+1.8%
$81.89
$56.46
$90.11
$11.80B1.171.27 million shs3.03 million shs
Crown Castle Inc. stock logo
CCI
Crown Castle
$90.66
-0.1%
$104.76
$89.64
$120.92
$39.40B0.862.72 million shs8.35 million shs
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
$20.12
+1.8%
$21.80
$16.01
$23.26
$14.07B1.135.66 million shs12.56 million shs
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$26.85
+2.3%
$26.44
$16.47
$28.81
$59.65B0.9513.86 million shs28.50 million shs
Altria Group, Inc. stock logo
MO
Altria Group
$53.84
+1.6%
$54.00
$39.25
$58.03
$93.08B0.636.94 million shs27.04 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.36
+2.3%
$26.82
$24.48
$31.54
$149.38B0.6539.04 million shs116.16 million shs
AT&T Inc. stock logo
T
AT&T
$22.75
+0.8%
$22.61
$15.94
$24.03
$163.24B0.5935.87 million shs92.77 million shs
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$39.93
-0.1%
$42.17
$37.15
$45.36
$168.09B0.4418.49 million shs46.43 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
+2.14%-8.08%+15.90%+9.64%-62.40%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
+1.83%+2.80%-0.95%+16.03%+12.52%
Boston Properties, Inc. stock logo
BXP
Boston Properties
+1.79%-6.60%-6.18%-7.87%+5.54%
Crown Castle Inc. stock logo
CCI
Crown Castle
-0.08%-6.63%-13.14%-21.39%-20.78%
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
+1.82%-3.08%-6.09%-8.59%+53.24%
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
+2.32%-0.15%-4.11%+23.22%+53.43%
Altria Group, Inc. stock logo
MO
Altria Group
+1.60%-1.98%-3.81%+6.85%+33.56%
Pfizer Inc. stock logo
PFE
Pfizer
+2.29%+3.05%+5.67%-10.40%-4.58%
AT&T Inc. stock logo
T
AT&T
+0.80%-3.72%-0.35%+5.62%+38.72%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
-0.10%-5.56%-5.42%-9.93%+7.05%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
4.2371 of 5 stars
3.91.02.52.33.11.70.6
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
4.735 of 5 stars
2.14.04.24.02.23.31.9
Boston Properties, Inc. stock logo
BXP
Boston Properties
4.5892 of 5 stars
3.23.02.51.81.51.73.1
Crown Castle Inc. stock logo
CCI
Crown Castle
4.6798 of 5 stars
4.13.01.72.93.41.71.3
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
4.7182 of 5 stars
3.43.02.53.73.01.71.9
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
4.1455 of 5 stars
2.33.01.70.82.84.21.9
Altria Group, Inc. stock logo
MO
Altria Group
3.9691 of 5 stars
2.14.04.20.03.00.81.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9738 of 5 stars
3.24.04.24.23.03.32.5
AT&T Inc. stock logo
T
AT&T
4.4371 of 5 stars
3.33.02.53.72.50.81.3
Verizon Communications Inc. stock logo
VZ
Verizon Communications
4.571 of 5 stars
3.23.02.53.52.21.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
1.87
Reduce$12.5831.70% Upside
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.25
Hold$55.64-2.94% Downside
Boston Properties, Inc. stock logo
BXP
Boston Properties
2.46
Hold$81.389.04% Upside
Crown Castle Inc. stock logo
CCI
Crown Castle
2.14
Hold$117.0029.05% Upside
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
2.75
Moderate Buy$22.9313.96% Upside
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
2.54
Moderate Buy$26.25-2.23% Downside
Altria Group, Inc. stock logo
MO
Altria Group
2.14
Hold$53.33-0.94% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.47
Hold$32.1421.94% Upside
AT&T Inc. stock logo
T
AT&T
2.68
Moderate Buy$25.5312.22% Upside
Verizon Communications Inc. stock logo
VZ
Verizon Communications
2.44
Hold$46.5116.49% Upside

Current Analyst Ratings

Latest High Dividend Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
12/20/2024
Verizon Communications Inc. stock logo
VZ
Verizon Communications
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$44.00 ➝ $45.00
12/19/2024
AT&T Inc. stock logo
T
AT&T
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$25.00 ➝ $30.00
12/18/2024
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$27.00 ➝ $30.00
12/18/2024
Pfizer Inc. stock logo
PFE
Pfizer
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$36.00 ➝ $32.00
12/17/2024
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$24.00 ➝ $27.00
12/16/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$63.00 ➝ $70.00
12/16/2024
AT&T Inc. stock logo
T
AT&T
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$19.00 ➝ $28.00
12/11/2024
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$35.00 ➝ $33.00
12/10/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral$63.00
12/10/2024
Crown Castle Inc. stock logo
CCI
Crown Castle
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeEqual Weight ➝ Underweight$105.00 ➝ $100.00
12/10/2024
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $22.00
(Data available from 12/21/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$147.66B0.06$5.28 per share1.81$13.91 per share0.69
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$47.44B2.45$12.60 per share4.55$14.49 per share3.96
Boston Properties, Inc. stock logo
BXP
Boston Properties
$3.38B3.49$6.08 per share12.27$52.15 per share1.43
Crown Castle Inc. stock logo
CCI
Crown Castle
$6.59B5.98$7.07 per share12.82$14.71 per share6.16
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
$543.46M25.89$1.65 per share12.16$12.57 per share1.60
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$15.15B3.94$2.12 per share12.68$14.27 per share1.88
Altria Group, Inc. stock logo
MO
Altria Group
$20.36B4.48$5.05 per share10.66($1.97) per share-27.33
Pfizer Inc. stock logo
PFE
Pfizer
$59.38B2.52$3.07 per share8.59$15.81 per share1.67
AT&T Inc. stock logo
T
AT&T
$122.06B1.34$4.89 per share4.65$16.42 per share1.39
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$134.24B1.25$8.48 per share4.71$22.31 per share1.79

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-$8.64B-$10.01N/A6.541.36-5.85%14.23%2.88%N/A
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$8.03B-$3.59N/A8.0015.20-15.30%11.94%2.51%N/A
Boston Properties, Inc. stock logo
BXP
Boston Properties
$190.21M$2.3132.3110.480.5510.75%4.40%1.40%N/A
Crown Castle Inc. stock logo
CCI
Crown Castle
$1.50B$2.8232.1513.76N/A18.59%20.98%3.20%N/A
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
$306.01M$0.4742.8110.762.3712.10%3.53%1.62%N/A
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$2.39B$1.1423.5521.143.8816.76%7.87%3.52%N/A
Altria Group, Inc. stock logo
MO
Altria Group
$8.13B$5.929.0910.123.0242.82%-233.80%24.32%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.7435.629.090.637.07%16.28%6.68%N/A
AT&T Inc. stock logo
T
AT&T
$14.40B$1.2318.5010.633.607.42%13.97%4.12%N/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$11.61B$2.3217.218.423.057.30%20.05%5.07%N/A

Latest High Dividend Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/31/2024Q3 2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.49$1.80+$0.31$3.00$11.26 billion$11.89 billion
10/31/2024Q3 2024
Altria Group, Inc. stock logo
MO
Altria Group
$1.35$1.38+$0.03$1.42$5.33 billion$6.26 billion
10/29/2024Q3 2024
Boston Properties, Inc. stock logo
BXP
Boston Properties
$1.81$0.53-$1.28$0.53$829.91 million$859.23 million
10/29/2024Q3 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.64$1.06+$0.42$1.34$14.92 billion$17.70 billion
10/24/2024Q3 2024
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
$0.44$0.12-$0.32$0.12$682.51 million$700.40 million
10/23/2024Q3 2024
AT&T Inc. stock logo
T
AT&T
$0.57$0.60+$0.03$1.23$30.50 billion$30.20 billion
10/22/2024Q3 2024
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$1.18$1.19+$0.01$1.60$33.42 billion$33.30 billion
10/16/2024Q3 2024
Crown Castle Inc. stock logo
CCI
Crown Castle
$1.73$0.70-$1.03$0.70$1.64 billion$1.65 billion
10/16/2024Q3 24
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$0.27$0.25-$0.02$0.22$4.05 billion$3.70 billion
10/15/2024Q4 2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$0.36$0.39+$0.03$4.26$35.75 billion$37.50 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$1.0010.47%+1.25%N/A N/A
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.484.33%-0.15%N/A 16 Years
Boston Properties, Inc. stock logo
BXP
Boston Properties
$3.925.25%N/A169.70%N/A
Crown Castle Inc. stock logo
CCI
Crown Castle
$6.266.90%+8.29%221.99%N/A
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
$1.205.96%+36.49%255.32%N/A
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$1.154.28%+2.74%100.88%N/A
Altria Group, Inc. stock logo
MO
Altria Group
$4.087.58%+4.14%68.92%56 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.53%+2.57%232.43%15 Years
AT&T Inc. stock logo
T
AT&T
$1.114.88%-18.89%90.24%N/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$2.716.79%+1.98%116.81%N/A

Latest High Dividend Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/12/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.78%1/24/20251/24/20253/7/2025
12/11/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.624.38%1/3/20251/3/20252/3/2025
12/12/2024
AT&T Inc. stock logo
T
AT&T
quarterly$0.27754.75%1/10/20251/10/20252/3/2025
12/5/2024
Verizon Communications Inc. stock logo
VZ
Verizon Communications
quarterly$0.67756.37%1/10/20251/10/20252/3/2025
12/18/2024
Boston Properties, Inc. stock logo
BXP
Boston Properties
quarterly$0.985.28%12/31/202412/31/20241/30/2025
12/11/2024
Altria Group, Inc. stock logo
MO
Altria Group
quarterly$1.027.5%12/26/202412/26/20241/10/2025
11/6/2024
Crown Castle Inc. stock logo
CCI
Crown Castle
Quarterly$1.56506.01%12/13/202412/13/202412/31/2024
10/24/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
quarterly$0.2510.71%11/18/202411/18/202412/12/2024
10/9/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.425.56%11/8/202411/8/202412/2/2024
10/24/2024
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
quarterly$0.305.3%11/4/202411/4/202411/15/2024
10/16/2024
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
quarterly$0.28754.6%10/31/202410/31/202411/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
0.67
0.68
0.37
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.83
1.24
1.09
Boston Properties, Inc. stock logo
BXP
Boston Properties
2.01
5.51
5.51
Crown Castle Inc. stock logo
CCI
Crown Castle
4.43
0.54
0.54
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
0.93
1.31
1.31
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
0.95
0.46
0.35
Altria Group, Inc. stock logo
MO
Altria Group
N/A
0.44
0.30
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
AT&T Inc. stock logo
T
AT&T
1.09
0.73
0.67
Verizon Communications Inc. stock logo
VZ
Verizon Communications
1.32
0.66
0.62

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
312,000864.62 million714.17 millionOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,1002.03 billion2.03 billionOptionable
Boston Properties, Inc. stock logo
BXP
Boston Properties
780158.11 million155.98 millionOptionable
Crown Castle Inc. stock logo
CCI
Crown Castle
4,700434.60 million432.90 millionOptionable
Healthpeak Properties, Inc. stock logo
DOC
Healthpeak Properties
200699.44 million697.35 millionOptionable
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
10,8912.22 billion1.94 billionOptionable
Altria Group, Inc. stock logo
MO
Altria Group
6,4001.69 billion1.69 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
AT&T Inc. stock logo
T
AT&T
149,9007.18 billion7.17 billionOptionable
Verizon Communications Inc. stock logo
VZ
Verizon Communications
105,4004.21 billion4.21 billionOptionable

High Dividend Stocks Headlines

Recent News About These Companies

Zacks Research Has Pessimistic View of VZ FY2025 Earnings
Verizon Communications Inc. stock logo
What is Zacks Research's Estimate for VZ FY2025 Earnings?
Verizon Sued for Racial Discrimination, Wrongful Termination

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Company Descriptions

Walgreens Boots Alliance logo

Walgreens Boots Alliance

NASDAQ:WBA
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Bristol-Myers Squibb logo

Bristol-Myers Squibb

NYSE:BMY
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Boston Properties logo

Boston Properties

NYSE:BXP
Boston Properties, Inc. (NYSE: BXP) (BXP or the Company) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by joint ventures, BXP's portfolio totals 53.3 million square feet and 188 properties, including 10 properties under construction/redevelopment. BXP's properties include 167 office properties, 14 retail properties (including two retail properties under construction/redevelopment), six residential properties (including one residential property under construction) and one hotel. BXP is well-known for its inhouse building management expertise and responsiveness to clients' needs. BXP holds a superior track record of developing premium Central Business District (CBD) office buildings, successful mixed-use complexes, suburban office centers and build-to-suit projects for a diverse array of creditworthy clients. BXP actively works to promote its growth and operations in a sustainable and responsible manner. BXP has earned a twelfth consecutive GRESB Green Star recognition and the highest GRESB 5-star Rating. BXP, an S&P 500 company, was founded in 1970 by Mortimer B. Zuckerman and Edward H. Linde and became a public company in 1997.
Crown Castle logo

Crown Castle

NYSE:CCI
Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 90,000 route miles of fiber supporting small cells and fiber solutions across every major U.S. market. This nationwide portfolio of communications infrastructure connects cities and communities to essential data, technology and wireless service - bringing information, ideas and innovations to the people and businesses that need them.
Healthpeak Properties logo

Healthpeak Properties

NYSE:DOC
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Kinder Morgan logo

Kinder Morgan

NYSE:KMI
Kinder Morgan, Inc. operates as an energy infrastructure company primarily in North America. The company operates through Natural Gas Pipelines, Products Pipelines, Terminals, and CO2 segments. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas gasification, liquefaction, and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, renewable fuel and feedstocks, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 82,000 miles of pipelines and 139 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was incorporated in 2006 and is headquartered in Houston, Texas.
Altria Group logo

Altria Group

NYSE:MO
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
AT&T logo

AT&T

NYSE:T
AT&T Inc. provides telecommunications and technology services worldwide. The company operates through two segments, Communications and Latin America. The Communications segment offers wireless voice and data communications services; and sells handsets, wireless data cards, wireless computing devices, carrying cases/protective covers, and wireless chargers through its own company-owned stores, agents, and third-party retail stores. It also provides Virtual Private Networks, AT&T Dedicated Internet, Ethernet, data services, cloud solutions, outsourcing, and managed professional services, as well as customer premises equipment for multinational corporations, small and mid-sized businesses, governmental, and wholesale customers. In addition, this segment offers broadband services, including fiber connections, legacy telephony voice communication services, and other VoIP services and equipment to residential customers. This segment markets its communications services and products under the AT&T, AT&T Business, Cricket, AT&T PREPAID, and AT&T Fiber brand names. The Latin America segment provides postpaid and prepaid wireless services in Mexico under the AT&T and Unefon brand names, as well as sells smartphones through its owned stores, agents and third-party retail stores. The company was formerly known as SBC Communications Inc. and changed its name to AT&T Inc. in 2005. AT&T Inc. was incorporated in 1983 and is based in Dallas, Texas.
Verizon Communications logo

Verizon Communications

NYSE:VZ
Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.